← Eichor
Study identifier: NCT05172245 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Condition: Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Head and Neck Carcinoma of Unknown Primary  ·  Sponsor: National Cancer Institute (NCI)

PhasePhase 1
Planned participants46
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy ("chemo-radiation") in patients with head and neck cancer. Ipatasertib is in a class of medications called protein kinase B (AKT) inhibitors. It may stop the growth of tumor cells and may kill them. Cisplatin, which is a chemotherapy used in this trial, is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Radiation therapy uses high energy to kill tumor cells and shrink tumors. Giving ipatasertib in combination with chemo-radiation may be better than chemo-radiation alone in treating patients with advanced head and neck cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (18)

Moffitt Cancer CenterTampa, Florida, United StatesRecruiting
Northwestern UniversityChicago, Illinois, United StatesRecruiting
University of Kansas Clinical Research CenterFairway, Kansas, United StatesRecruiting
University of Kansas Cancer CenterKansas City, Kansas, United StatesRecruiting
University of Kansas Hospital-Westwood Cancer CenterWestwood, Kansas, United StatesRecruiting
University of Kentucky/Markey Cancer CenterLexington, Kentucky, United StatesActive Not Recruiting
University of Maryland/Greenebaum Cancer CenterBaltimore, Maryland, United StatesRecruiting
Rutgers Cancer Institute of New JerseyNew Brunswick, New Jersey, United StatesRecruiting
Rutgers New Jersey Medical SchoolNewark, New Jersey, United StatesRecruiting
Montefiore Medical Center-Einstein CampusThe Bronx, New York, United StatesRecruiting
Montefiore Medical Center - Moses CampusThe Bronx, New York, United StatesRecruiting
Carolinas Medical Center/Levine Cancer InstituteCharlotte, North Carolina, United StatesActive Not Recruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05172245